Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 11, 2022

SELL
$3.59 - $8.34 $981,297 - $2.28 Million
-273,342 Closed
0 $0
Q3 2021

Nov 15, 2021

BUY
$3.22 - $4.09 $17,523 - $22,257
5,442 Added 2.03%
273,342 $985,000
Q2 2021

Aug 16, 2021

SELL
$3.18 - $4.8 $64,560 - $97,449
-20,302 Reduced 7.04%
267,900 $1.03 Million
Q1 2021

May 13, 2021

SELL
$3.74 - $4.94 $58,209 - $76,886
-15,564 Reduced 5.12%
288,202 $1.1 Million
Q4 2020

Feb 17, 2021

BUY
$2.37 - $4.5 $204,149 - $387,625
86,139 Added 39.58%
303,766 $1.17 Million
Q3 2020

Nov 13, 2020

BUY
$2.44 - $3.2 $62,183 - $81,552
25,485 Added 13.26%
217,627 $548,000
Q2 2020

Aug 13, 2020

BUY
$1.83 - $3.25 $93,342 - $165,772
51,007 Added 36.14%
192,142 $593,000
Q1 2020

May 13, 2020

SELL
$2.25 - $4.71 $11,646 - $24,378
-5,176 Reduced 3.54%
141,135 $353,000
Q4 2019

Feb 14, 2020

BUY
$3.38 - $5.94 $494,531 - $869,087
146,311 New
146,311 $518,000

Others Institutions Holding SRTS

About Sensus Healthcare, Inc.


  • Ticker SRTS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 16,556,000
  • Market Cap $81.6M
  • Description
  • Sensus Healthcare, Inc., a medical device company, manufactures and sells radiation therapy devices to healthcare providers worldwide. The company uses superficial radiation therapy (SRT), a low-energy X-ray technology in its portfolio of treatment devices. It offers SRT-100, a photon X-ray low energy superficial radiotherapy system that provide...
More about SRTS
Track This Portfolio

Track Invenomic Capital Management LP Portfolio

Follow Invenomic Capital Management LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Invenomic Capital Management LP, based on Form 13F filings with the SEC.

News

Stay updated on Invenomic Capital Management LP with notifications on news.